ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

First test of pluripotent stem cell therapy in monkeys is a success – Science Codex

First test of pluripotent stem cell therapy in monkeys is a successScience CodexResearchers have shown for the first time in an animal that is more closely related to humans that it is possible to make new bone from stem–cell-like induced pluripotent stem cells (iPSCs) made from an individual animal’s own skin cells. The study in … Continue reading

2014-05-15 Michael Zand NEWS

Mice with MS-like condition walk again after human stem cell treatment – Science Codex

Science Codex(SALT LAKE CITY) – Mice severely disabled by a condition similar to multiple sclerosis (MS) were able to walk less than two weeks following treatment with human neural stem cells. The finding, which uncovers potential new avenues for treating MS, will … …read more   &nbs… Continue reading

2014-05-15 Michael Zand NEWS

Stem cell therapy shows promise for MS in mouse model – Science Codex

Stem cell therapy shows promise for MS in mouse modelScience CodexLoring’s group at TSRI has been searching for another way to treat MS using human pluripotent stem cells, which are cells that have the potential to transform into any of the cell types in the body. Loring’s group has been focused on turning human stem … Continue reading

2014-05-15 Michael Zand NEWS

Stem cell therapy shows promise for MS in mouse model – EurekAlert (press release)

Stem cell therapy shows promise for MS in mouse modelEurekAlert (press release)Remarkably, the mice recovered even after their bodies rejected the human stem cells. “When we implanted the human cells into mice that were paralyzed, they got up and started walking a couple of weeks later, and they completely recovered over the next … …read … Continue reading

2014-05-15 Michael Zand NEWS

Scientists Get Closer to the Stem Cells That May Drive Cancers – HealthDay

Scientists Get Closer to the Stem Cells That May Drive CancersHealthDayTHURSDAY, May 15, 2014 (HealthDay News) — Although the very concept of cancer stem cells has been controversial, new research provides proof that these distinct types of cells exist in humans. Using genetic tracking, researchers found that a gene … …read more   &nbs… Continue reading

2014-05-15 Michael Zand NEWS

Genetic tracking identifies cancer stem cells in human patients – Medical Xpress

Genetic tracking identifies cancer stem cells in human patientsMedical XpressThe gene mutations driving cancer have been tracked for the first time in patients back to a distinct set of cells at the root of cancer – cancer stem cells. The international research team, led by scientists at the University of Oxford and the …Scientists Get … Continue reading

2014-05-15 Michael Zand NEWS

Stem cell therapy shows promise for multiple sclerosis in mouse model – Medical Xpress

Medical XpressRemarkably, the mice recovered even after their bodies rejected the human stem cells. “When we implanted the human cells into mice that were paralyzed, they got up and started walking a couple of weeks later, and they completely recovered over the next …Mice With MS-Like Condition Walk Again After Human Stem Cell TreatmentNewswise (press … Continue reading

2014-05-15 Michael Zand NEWS

A Fetal Enzyme Helps Stem Cells Recover From Limb Injuries – RedOrbit

RedOrbitTheir study, published in PLOS ONE, reveals that one way stem cell therapy appears to intervene is with the help of an enzyme also used by a fetus to escape rejection by the mother’s immune system. Baban notes that previous studies have found a … …read more   &nbs… Continue reading

2014-05-15 Michael Zand NEWS
  • 1
  • …
  • 3,137
  • 3,138
  • 3,139
  • 3,140
  • 3,141
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.